Review
Neurological complications in renal failure: a review

https://doi.org/10.1016/j.clineuro.2004.07.012Get rights and content

Abstract

Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic advances, many neurological complications of uremia, like uremic encephalopathy, atherosclerosis, neuropathy and myopathy fail to fully respond to dialysis. Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis can directly or indirectly be associated with dialysis dementia, dysequilibrium syndrome, aggravation of atherosclerosis, cerebrovascular accidents due to ultrafiltration-related arterial hypotension, hypertensive encephalopathy, Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and mononeuropathy. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease. The use of immunosuppressive drugs after renal transplantation can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. We address the clinical, pathophysiological and therapeutical aspects of both central and peripheral nervous system complications in uremia.

Introduction

Patients with renal failure often have signs and symptoms related to fluid and electrolyte disturbances, anemia, malnutrition, bone disease and gastrointestinal problems. Vascular and neurologic impairment in particular remain an important source of morbidity and mortality in this vulnerable patient population.

In this paper, disease related and treatment related neurological complications in renal failure will be reviewed. With the introduction of dialysis and renal transplantation, the spectrum of neurological complications changed. The incidence and severity of uremic encephalopathy, atherosclerosis, neuropathy and myopathy have declined but many patients fail to fully respond to dialytic therapy.

Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis dementia, dialysis dysequilibrium syndrome, hypertensive encephalopathy and cerebrovascular accident due to ultrafiltration-related arterial hypotension can occur as a direct consequence of dialysis. Furthermore, dialysis is associated with aggravation of atherosclerosis and can contribute to the development of Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and neuropathy. Patients with renal failure may benefit from kidney transplantation, but the use of immunosuppressive drugs can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease (Table 1). In what follows, we will address both central and peripheral nervous system complications in patients with renal failure.

Section snippets

Encephalopathy

In patients with renal failure, encephalopathy is a common problem that may be caused by uremia, thiamine deficiency, dialysis, transplant rejection, hypertension, fluid and electrolyte disturbances or drug toxicity [1] (Table 2). In general, encephalopathy presents with a symptom complex progressing from mild sensorial clouding to delirium and coma. It is often associated with headache, visual abnormalities, tremor, asterixis, multifocal myoclonus, chorea and seizures. These signs fluctuate

Mononeuropathy

In uremia, susceptibility of the peripheral nerves to compression and local ischemia is increased. In practice especially the ulnar, median and femoral nerves are affected (Table 3).

Damage to the ulnar nerve can occur by uremic tumoral calcinosis at the wrist, in Guyon's canal [172]. Depending on the site of compression in the canal, this may cause purely motor dysfunction with paresis of intrinsic hand muscles, sensory loss to the hypothenar eminence, the small finger and the lateral part of

Conclusion

Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic progress, most neurological complications of uremia fail to fully respond to dialysis and many are elicited or aggravated by dialysis or renal transplantation.

In order to assure optimal care for patients with renal failure, both neurologists and nephrologists should be familiar with the neurologic

References (221)

  • K. Berend et al.

    Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe

    Kidney Int

    (2001)
  • J.R. Mach et al.

    Dialysis dementia

    Clin Geriatr Med

    (1988)
  • M.L. Gross et al.

    Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation

    J Neurol Sci

    (1982)
  • S.M. Silver et al.

    Brain swelling after dialysis: old urea or new osmoles?

    Am J Kidney Dis

    (1996)
  • S.M. Silver et al.

    Dialysis disequilibrium syndrome (DDS) in the rat: role of the “reverse urea effect”

    Kidney Int

    (1992)
  • L.A. Pedrini et al.

    Causes, kinetics and clinical implications of post-hemodialysis urea reboud

    Kidney Int

    (1988)
  • C. Ichai et al.

    Osmolality and brain

    Ann Fr Anesth Reanim

    (1994)
  • J.E. Riggs

    Neurologic manifestations of fluid and electrolyte disturbances

    Neurol Clin

    (1989)
  • W.C. Cheung et al.

    Isoniazid-induced encephalopathy in dialysis patients

    Tuber Lung Dis

    (1993)
  • A. Tartini et al.

    Encainide-induced encephalopathy in a patient with chronic renal failure

    Am J Kidney Dis

    (1990)
  • D.A. Sica et al.

    Pseudoephedrine accumulation in renal failure

    Am J Med Sci

    (1989)
  • S.H. Chang et al.

    Cyclosporine-associated encephalopathy: a case report and literature review

    Transplant Proc

    (2001)
  • A.K. Scheel et al.

    Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports

    Transplant Proc

    (2001)
  • S. Inoha et al.

    Magnetic resonance imaging in cases with encephalopathy secondary to immunosuppressive agents

    J Clin Neurosci

    (2002)
  • H. Ikesue et al.

    Cyclosporine enhances alpha1-adrenoceptor-mediated nitric oxide production in C6 glioma cells

    Eur J Pharmacol

    (2000)
  • K.M. Chow et al.

    Nonconvulsive status epilepticus in peritoneal dialysis patients

    Am J Kidney Dis

    (2001)
  • A.K. Cheung et al.

    Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

    Kidney Int

    (2000)
  • A. Torremans et al.

    Effect of NaCN on currents evoked by uremic retention solutes in dissociated mouse neurons

    Brain Res

    (2004)
  • M. Peppa et al.

    Glycoxidation and inflammation in renal failure patients

    Am J Kidney Dis

    (2004)
  • S. Vicca et al.

    New insights into the effects of the protein moiety of oxidized LDL

    Kidney Int Suppl

    (2003)
  • J. Uribarri et al.

    Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients

    Am J Kidney Dis

    (2003)
  • C.L. Lin et al.

    Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients

    Am J Kidney Dis

    (2003)
  • Z.A. Massy

    Potential strategies to normalize the levels of homocysteine in chronic renal failure patients

    Kidney Int Suppl

    (2003)
  • A. Van Tellingen et al.

    Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients

    Kidney Int

    (2001)
  • F. Galli et al.

    The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels

    Kidney Int

    (2003)
  • P.S. Parfrey

    Cardiac and cerebrovascular disease in chronic uremia

    Am J Kidney Dis

    (1993)
  • M.J. Aminoff
  • D.J. Burn et al.

    Neurology and the kidney

    J Neurol Neurosurg Psychiatry

    (1998)
  • P.P. De Deyn et al.

    Clinical and pathophysiological aspects of neurological complications in renal failure

    Acta Neurol Belg

    (1992)
  • G. Dunea

    Dialysis dementia: an epidemic that came and went

    ASAIO J

    (2001)
  • T.D. McKinney et al.

    Serum aluminum levels in dialysis dementia

    Nephron

    (1982)
  • D.N. Kerr et al.

    Aluminium intoxication in renal disease

    Ciba Found Symp

    (1992)
  • P. Hernandez et al.

    Deferoxamine for aluminium toxicity in dialysis patients

    ANNA J

    (1990)
  • M.L. Gross et al.

    Rejection encephalopathy

    Proc Eur Dial Transplant Assoc

    (1981)
  • J.D. Port et al.

    Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction

    Radiographics

    (1998)
  • J.W. Eschbach et al.

    Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

    Ann Intern Med

    (1989)
  • A. Sikole et al.

    Epoetin omega for treatment of anemia in maintenance hemodialysis patients

    Clin Nephrol

    (2002)
  • N. Delanty et al.

    Erythropoietin-associated hypertensive posterior leukoencephalopathy

    Neurology

    (1997)
  • A.E. Raine et al.

    Effects of erythropoietin on blood pressure

    Am J Kidney Dis

    (1991)
  • J. Walter et al.

    The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients

    Artif Organs

    (1995)
  • Cited by (331)

    • Approach to blunt, sharp, and transportation deaths

      2022, Principles of Forensic Pathology: From Investigation to Certification
    View all citing articles on Scopus
    View full text